Disclaimer: That Intended For Medical Professionals Only
AjantaMed Dialogue
Log In/Register
AjantaMed Dialogue
Stay Informed, Stay Ahead
Latest News :
New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management • New Heart Health Study Shows Positive Results • PharmaCare Launches New Immunity Formula • Quality Healthcare Products • Breakthrough Announced in Pain Management •
sticky-medbot
Cyclosporine vs Lifitegrast: Clinical Decision-Making in Dry Eye Disease

Cyclosporine vs Lifitegrast: Clinical Decision-Making in Dry Eye Disease

When managing inflammatory dry eye disease, selecting the right immunomodulatory therapy is key to achieving optimal outcomes. This video explores how clinicians decide between cyclosporine and lifitegrast in routine practice and discusses the limitations and considerations of each therapy.

By : Dr. Eric Donnenfled

Recommended Videos

Dr Elankumaran Pasupathi – Case Study 5
Ophthalmology

Dr Elankumaran Pasupathi – Case Study 5

Dr Harshvardhan Ghorpade – Case 4
Ophthalmology

Dr Harshvardhan Ghorpade – Case 4

Dr Bhaskar Srinivasan – Case 3
Ophthalmology

Dr Bhaskar Srinivasan – Case 3

Dr Madhu Uddaraju – Case 2
Ophthalmology

Dr Madhu Uddaraju – Case 2

Subscribe to our newsletter

Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.